Jasper Ridge Partners’s Histogen Inc. Common Stock HSTO Stock Holding History

Jasper Ridge Partners’s Portfolio HSTO Stock Details HSTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-78	Closed	-$86K	–	81
2017 Q3	$86K	Hold	78	–	–	﹤0.01%	78
2017 Q2	$90K	Hold	78	–	–	﹤0.01%	83
2017 Q1	$90K	Sell	78 -159	-67%	-$153K	0.01%	92
2016 Q4	$250K	Buy	+237	New	+$108K	0.02%	88
2015 Q4	–	Sell	-107	Closed	-$95K	–	95
2015 Q3	$95K	Hold	107	–	–	0.01%	83
2015 Q2	$110K	Hold	107	–	–	0.01%	90
2015 Q1	$152K	Hold	107	–	–	0.01%	88
2014 Q4	$149K	Sell	107 -116	-52%	-$168K	0.01%	80
2014 Q3	$273K	Sell	223 -97	-30%	-$139K	0.02%	101
2014 Q2	$583K	Hold	320	–	–	0.04%	86
2014 Q1	$521K	Buy	+320	New	+$669K	0.03%	87

Other funds holding HSTO

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Jasper Ridge Partners's HSTO Position: Q4 2017 in Review

Jasper Ridge Partners sold out of Histogen Inc. Common Stock (HSTO) in Q4 2017, closing a stake of 78 shares — an estimated $86K sold.

Jasper Ridge Partners first reported a position in HSTO in Q1 2014 and held it in 11 quarters. The position peaked at $583K in Q2 2014. 70 funds tracked by Wall St. Rank hold HSTO as of Q4 2017.

Jasper Ridge Partners reported no remaining Histogen Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Jasper Ridge Partners sold 78 Histogen Inc. Common Stock shares in Q4 2017, an estimated $86K.
Jasper Ridge Partners first reported a position in Histogen Inc. Common Stock in Q1 2014 and held it in 11 quarters.
Jasper Ridge Partners's Histogen Inc. Common Stock position peaked at $583K in Q2 2014.
70 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2017.

Based on Jasper Ridge Partners's 13F filing for Q4 2017, filed 14 Feb 2018.